Ph.D. in Biomedical Technologies in Clinical Medicine, holds a Bachelor’s Degree in Biological Sciences majoring in Molecular Biology and a Master’s Degree majoring in Cellular Biology from La Sapienza University of Rome. In 2010 he worked at the Pfizer Center for Plant Genomics, Botanical Garden, New York,USA. In 2013 Holder of a fellowship at the Department of Biology, Biotechnology and Genetics Peking University, Beijing Shi, China. Since 2016 researcher at IRCCS San Raffaele Rome, Italy. Participated as a collaborator in the Finalized Research Project Clinical relevance of miR-142-3p as potential biomarker of synaptopathy in Multiple Sclerosis. RF-2018-12366144 PI Diego Centonze. He is sub-unit in Grant No. PRIN – 2022HX33LS – Clinical, molecular and pathogenic bases of familial adult myoclonic epilepsies caused by pentanucleotide repeat expansions in the non-coding genome (PI Prof. Brancati). He is PI of a Unit in CNR project FOE2022 – Identification of possible SNPs in the DNA-PK complex as a potential peripheral biomarker of Alzheimer’s Disease.
